Graham Jang, Ph.D., M.B.A., is Silverback’s vice president of Development Sciences. He has over 20 years of industry experience spanning drug discovery through all stages of development. Graham had leadership roles in multiple new and supplemental biologics drug approvals at Seattle Genetics and Amgen, where he led translational medicine and clinical pharmacology groups. He joined Silverback from Regulus Therapeutics, where he was vice president of drug metabolism and pharmacokinetics. Early in his career, he worked in drug discovery at Bristol-Myers Squibb. Graham received his Ph.D. in Pharmaceutical Chemistry from University of California, San Francisco, completed a post-doctoral fellowship with INSERM (Montpellier, France), and more recently received his M.B.A. from the Wharton School at the University of Pennsylvania.